Skip to content

Earnings Screener Charts Portfolio Pricing

Connect your AI

Stocks
BioCryst Pharmaceuticals
Business Segments
Products & Services
Royalty purchase agreement, royalties paid and payable

Royalty purchase agreement, royalties paid and payable

BioCryst Pharmaceuticals·Products & Services·1 segment

Breakdown

Segments

ORLADEYOView metric

Explore

Earnings Calendar
Stock Screener
Metrics Screener
Charts
Watchlist
Portfolio

Resources

Pricing
Releases
About
Contact
Methodology
Cite & Reuse
Sign in / Sign up

Connect

Claude
Claude Code
ChatGPT
Codex
Codex CLI
Cursor
Other clients

Legal

Privacy Policy
Terms of Service
Cookie Policy
SEC EDGAR
support@opencapital.sh

© 2026 OpenCapital. All rights reserved.

Data sourced from SEC filings — methodology

OpenCapital is not affiliated with or endorsed by the U.S. Securities and Exchange Commission (SEC). All data is sourced from publicly available SEC filings.

Segment	Q1 '26
ORLADEYO	$103.41M
Total	$103.41M